XOMA Royalty (XOMA) Non Operating Investment Income (2024 - 2026)

XOMA Royalty's (XOMA) quarterly Non Operating Investment Income came in at $933000.0 in Q1 2026, up 0.65% year-on-year from $927000.0 in Q1 2025, and up 12.0% quarter-over-quarter from $833000.0 in Q4 2025.

XOMA Royalty (XOMA) Non Operating Investment Income (2024 - 2026) Analysis & Trends

XOMA Royalty has disclosed Non Operating Investment Income across 3 years of filings, most recently posting $933000.0 for Q1 2026.

  • Non Operating Investment Income for Q1 2026 came in at $933000.0, up 0.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (down 39.16% YoY), and the FY2025 annual result was $3.5 million, down 46.56% from the prior year.
  • Non Operating Investment Income came in at $933000.0 for Q1 2026 at XOMA Royalty, up from $833000.0 in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $1.7 million in Q3 2024 to a low of $833000.0 in Q4 2025.
  • The 3-year median for Non Operating Investment Income is $930000.0 (2025), against an average of $1.1 million.
  • Across the five-year window, Non Operating Investment Income plunged 49.88% in 2025 and gained 0.65% in 2026, its largest moves.
  • XOMA Royalty's Non Operating Investment Income stood at $1.4 million in 2024, then slumped by 40.71% to $833000.0 in 2025, then advanced by 12.0% to $933000.0 in 2026.
  • The last three Non Operating Investment Income figures came in at $933000.0 (Q1 2026), $833000.0 (Q4 2025), and $866000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 235,807.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 230,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 XOMA Royalty 5.48 Mn -60.60 Mn - 933,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 933,000.00
Mar 31, 2026 933,000.00
Dec 31, 2025 833,000.00
Dec 31, 2025 833,000.00
Sep 30, 2025 866,000.00
Sep 30, 2025 866,000.00
Jun 30, 2025 843,000.00
Jun 30, 2025 843,000.00
Mar 31, 2025 927,000.00
Mar 31, 2025 927,000.00
Dec 31, 2024 1.41 Mn
Dec 31, 2024 1.41 Mn
Sep 30, 2024 1.70 Mn
Sep 30, 2024 1.70 Mn
Jun 30, 2024 1.68 Mn
Jun 30, 2024 1.68 Mn